Bupivacaine Liposomes vs. Bupivacaine for pain relief after laparoscopic hepatobiliary pancreatic surgery
Official title: Effect of Bupivacaine Liposomes or Bupivacaine for Ultrasound-guided CMB on Postoperative Analgesia in Laparoscopic Hepatobiliary Pancreatic Surgery: a Prospective, Single Blind, Completely Randomized, Active Controlled Clinical Trial
Run by Huazhong University of Science and Technology · NCT06737341 · Data updated 2026-11-12
This trial tests whether liposome-encapsulated bupivacaine provides better postoperative pain relief than standard bupivacaine for people undergoing laparoscopic hepatobiliary pancreatic surgery.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Huazhong University of Science and Technology Academic / other |
| Locations | 2 sites (Wuhan, Hubei and 1 other locations) |
| Status | Recruiting |
| Started | October 8, 2025 |
| Main results expected | February 1, 2027 |
| Study ends | February 1, 2027 |
| Registry record updated | July 6, 2026 |
| Trial ID | NCT06737341 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–80 years old with ASA I–III undergoing laparoscopic hepatobiliary pancreatectomy or similar hepatobiliary procedures.
✕Probably not a fit
Patients who do not respond to regional anesthesia or who have contraindications to regional blocks or Liposomal bupivacaine may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In this randomized phase 4 study, adults undergoing laparoscopic hepatobiliary pancreatic surgery receive an ultrasound-guided costal margin block with either bupivacaine liposomes plus standard bupivacaine or standard bupivacaine alone. All participants follow a standardized anesthesia and postoperative analgesia protocol, with pain monitored via the visual analog scale and managed with an opioid-sparing regimen as needed. The primary aim is to determine if the liposomal formulation extends analgesia and reduces opioid requirements compared with conventional bupivacaine. Safety data, including adverse events related to nerve blocks and local anesthetics, are collected throughout the postoperative period. The study uses a complete randomization scheme and compares outcomes between the two groups."
Why it matters
Potential benefit: If successful, patients may experience longer-lasting pain control and reduced opioid use after surgery.
How similar studies have gone: Previous regional anesthesia studies show promise for liposomal formulations, with some trials indicating longer analgesia but results vary by procedure.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-80 years old ASA Level I-III Laparoscopic Hepatobiliary Pancreatic Surgery Exclusion Criteria: * Body Mass Index (BMI) ≥ 30 kg/m ² or ≤ 15 kg/m ² Known alcohol or drug abuse History of upper abdominal surgery Congenital coagulation dysfunction Localized or systemic infection Peripheral neuropathy Unable to understand the research plan
Where it's running
-
Tongji Hospital
Wuhan, Hubei, China Recruiting -
Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology. 1095 Jiefang Avenue, Wuhan City, Hubei Province
Wuhan, Hubei, China Not yet recruiting
Study contacts
- Principal investigator: Wei Mei, MD — Tongji Medical College, Huazhong University of Science and Technology
- Study coordinator: Li Xu, MD
- Email: 65022661@qq.com
- Phone: 86-13277070358
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intraparotid injection of bupivacaine with dexamethasone after partial parotidectomy
This early-phase study tests whether a single intraparotid injection of bupivacaine with dexamethasone is safe and tolerable after partial parotidectomy for a benign tumor.
-
Adding dexmedetomidine to spinal bupivacaine for pain relief during knee surgery
This trial tests whether small intrathecal doses of dexmedetomidine added to spinal bupivacaine can prolong pain relief after knee surgery in adult men.
-
Ultrasound-Guided Rhomboid-Intercostal Block vs Thoracic Paravertebral Block for Pain Control After VATS
This study tests whether the rhomboid-intercostal block (RIB) or the thoracic paravertebral block (PVB) provides better pain relief after a 3-port VATS chest surgery in adults.
-
Dexamethasone and Bupivacaine in a Shoulder Nerve Block: How It Affects Blood Levels
This study tests whether giving dexamethasone with a shoulder block affects the blood level of bupivacaine after a single injection.
-
Intrathecal dexmedetomidine plus fentanyl with bupivacaine for spinal anesthesia during above-knee amputation
This trial will test whether adding intrathecal dexmedetomidine to fentanyl and bupivacaine gives better and longer pain relief after above-knee amputation for adults with lower-limb sarcoma.
-
Comparing dexmedetomidine and bupivacaine for pain management after brain surgery
This study is testing if adding dexmedetomidine to bupivacaine can help reduce pain better after brain surgery compared to using bupivacaine alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.